Skip to content
GLP-1 Desk
Menu
Dispatch #20Editorial

Mochi Health

Low pricing inside a well-known app, but coverage stops at fifteen states and lacks third-party verification.

Visit Mochi HealthEditorial — no commercial relationship.
Semaglutide
$138/mo
Tirzepatide
$238/mo
Coverage
AZ, CO, FL, GA, IL, MA, MD, MN, NY, OR, PA, RI, TX, VA, WA
Brand-name
Compounded only

Desk Score breakdown

Each of the six scored dimensions. See the methodology.

Price transparency86/100
State access72/100
Molecule range80/100
Onboarding speed80/100
Support responsiveness78/100
Licensing & trust74/100

What the Desk likes

  • Low semaglutide pricing
  • Polished, well-known app experience
  • Both molecules available

Where points come off

  • Only fifteen states served
  • No LegitScript verification
  • Injectable only

The Desk's briefing — C+

Best for: Cost-conscious patients in a covered state who want a polished, app-first experience.

Mochi Health ranks #20 of 25 providers scored — see #1, CoreAge Rx on the board.

Related dispatches

Pricing and verification reflect Mochi Health's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on Mochi Health's site. Not medical advice; see our disclosure.

← Back to The Desk